Eagle Health Investments »

Alkermes shares owned by Eagle Health Investments

Quarter-by-quarter ownership of Alkermes (ALKS) shares owned by Eagle Health Investments from 13F filings

Historical chart of Eagle Health Investments investment in Alkermes

Tip: Access up to 7 years of quarterly data

All positions including Alkermes held by Eagle Health Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alkermes by Eagle Health Investments

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.5M 82k 30.00

More positions owned by Eagle Health Investments

Argenx Se Sponsored Adr (ARGX)
Insmed Com Par $.01 (INSM)
Natera (NTRA)
Icon SHS (ICLR)
Illumina (ILMN)
Neurocrine Biosciences (NBIX)
Ultragenyx Pharmaceutical (RARE)
BioMarin Pharmaceutical (BMRN)
Guardant Health (GH)
EXACT Sciences Corporation (EXAS)
Scholar Rock Hldg Corp (SRRK)
Bridgebio Pharma (BBIO)
Procept Biorobotics Corp (PRCT)
Alnylam Pharmaceuticals (ALNY)
Akero Therapeutics (AKRO)

View all positions for Eagle Health Investments

Top funds holding Alkermes

BlackRock
Vanguard Group
State Street Corporation
Baker Bros. Advisors
Renaissance Technologies
American Century Companies
Geode Capital Management
Jpmorgan Chase & Co
Dimensional Fund Advisors
Commodore Capital
PRIMECAP Management Company
Holocene Advisors
venBio Select Advisor
Nuveen
Charles Schwab Investment Management

View all funds holding Alkermes